Search

everythinglearnresearchcommunity

for

Search:↓

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

Memory regulatory T cells need IL-7, not IL-2, to stay in peripheral tissues.

Blocking IL-12/IL-23p40 helped reverse severe hair loss in patients.

IL-25 helps heal diabetic wounds by improving blood vessel and skin cell functions.

The study's results on the effectiveness of low-dose IL-2 for alopecia areata and its impact on immune cells were not provided.

IFN-γ and IL-2 are important for T cell activation in hair loss in mice.

Blocking IL-12/IL-23 does not help with hair loss in alopecia areata for mice or humans.

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.

Increasing Treg cells in the skin does not cure hair loss from alopecia areata in mice.

Ustekinumab treatment may reveal a genetic tendency for steatocystoma multiplex in psoriasis patients.

IL-27 may help prevent hair loss by creating immune-suppressing cells.

A humanized IL-2 fusion protein boosts T regulatory cells and helps control hair loss in Alopecia Areata.

Ritlecitinib may help treat alopecia areata by protecting hair follicles.

Higher IL-17A and IL-23 levels are linked to alopecia areata severity and could help in tracking and treating the disease.

Higher IL-21 levels may help predict alopecia areata activity.

IL-27 can prevent hair loss in alopecia areata.

IL-26 has antimicrobial and pro-inflammatory effects in the chronic skin condition Hidradenitis Suppurativa.

1,25-(OH)2D3 helps hair grow by blocking certain harmful signals.

Blocking TYK2 might be a new way to treat hair loss from alopecia areata.

Blocking certain proteins can significantly regrow hair in severe alopecia areata.

Inhibiting TYK2 can restore hair growth in alopecia areata.

The study identified and characterized new keratin genes linked to hair follicles and epithelial tissues.

Certain proteins and cytokines are key in causing psoriatic skin issues.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

CD8+ T cells play a key role in graft-versus-host disease in certain mice models.

IL-2 treatment causes skin eruptions and other reversible side effects, and may play a role in psoriasis.

Alopecia areata involves immune system imbalances that may lead to depression and anxiety.